Abstract
Rodrigo S Horta, Larissa M Souza, Bruna V Sena, Isabella O Almeida, Tâmara A Jaretta, Marcela M Pimenta and Archivaldo Reche Júnior
J Feline Med Surg 2021; 23: 86–97.
Readers should note that the version of the article that was published OnlineFirst in July 2020 and which was online until August 2020 has been amended. The version now appearing online and on pages 86’97 of the Feburary 2021 print issue of JFMS is the correct one. For information, the following amendment has been made to the original published version.
In the ‘Materials and methods’ section (sixth paragraph), the chlorambucil dose should be ‘2 mg/cat’ and not ‘2 mg/kg’, as previously stated. The sentence has therefore been amended to ‘For cats in remission after finishing the 20-week protocol, a maintenance phase was initiated with chlorambucil 2 mg/cat Monday–Wednesday–Friday for 8 weeks, and vincristine 0.75 mg/m2 intraperitoneally as follows: two with a 2-week interval; three with a 3-week interval; four with a 4-week interval; and every 6 weeks until 2 years from diagnosis.’